Skip to main content

Day: January 13, 2022

POAI Reports Strong Results From Its AI Cancer Drug Evaluation  

MINNEAPOLIS, Jan. 13, 2022 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) reported the preliminary results of its Discovery 2021 program today, announcing that its Helomics subsidiary’s evaluation demonstrated their proprietary Artificial Intelligence (AI) program CoRE™ (Computational Research Engine), combined with their tumor profile data and matched ovarian cancer samples, could identify potential new chemotherapy drug uses. These drugs are not currently approved for ovarian cancer, but, with further study, could be used for ovarian cancer treatment following clinical trial and regulatory approval. The Discovery 2021 program has combined Helomics’ proprietary knowledgebase, its AI Machine Learning Program and its TruTumor™ platform to create PeDAL™ (Patient-centric Discovery by Active Learning). PeDAL is a unique...

Continue reading

ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operations

Seasoned Executive Brings Significant Operational and Commercial Experience to Accelerate the Company’s Growth SAN CLEMENTE, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the appointment of Michael Bordainick as its Senior Vice President, Commercial Operations. In this newly created role, as part of the Company’s next phase of operational growth, Mr. Bordainick will be responsible for strengthening the strategic development and executional efficiencies of the sales and marketing teams. “As Michael brings significant experience and capabilities to advance ReShape’s recently launched commercial programs, including direct-to-consumer marketing and enhanced support for our clinical customers, he will be...

Continue reading

Skyharbour’s Partner Company Azincourt Energy Provides Update on Camp Construction and Drill Mobilization at East Preston Uranium Project, Saskatchewan

Vancouver, BC, Jan. 13, 2022 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt”) is pleased to announce that construction of the exploration camp for the winter 2022 exploration program is underway at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada. Project Location – Western Athabasca Basin, Saskatchewan, Canada:https://www.skyharbourltd.com/_resources/maps/Sky_EastPreston_20211209.jpg Discovery Mining Services is building the exploration camp at Snoop Lake and will maintain, staff, and manage the camp for the duration of the program, under the supervision of TerraLogic Exploration Inc. In addition, drilling and geological crews will be arriving on-site in the next few days, and drilling...

Continue reading

Mullen Automotive Electric Vehicle Program Update

Mullen updates shareholders on key efforts for Mullen FIVE and Mullen EV Cargo Van Programs BREA, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today an update for Mullen Shareholders on the Mullen FIVE EV Crossover Program and the Mullen EV Cargo Van Program. “I am excited to share updates about our vehicle programs for our valued shareholders.  The Mullen team has been working diligently on key initiatives both here in Southern California and outside Tunica, Mississippi, at our AMEC manufacturing facility for both our FIVE EV Crossover and EV Cargo Van programs,” said David Michery, CEO and chairman of Mullen Automotive. Mullen FIVE Program The Mullen engineering team, along with...

Continue reading

Muscle Maker, Inc. Adds Franchise Sales and Training Team To Support Expansion Plans

Brand adds two franchise sales leaders and corporate trainer to strengthen infrastructure LEAGUE CITY, TEX., Jan. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Muscle Maker, Inc. (Nasdaq: GRIL), the parent Company of Pokemoto, Superfit Foods and Muscle Maker Grill restaurants, today announced the addition of three new team members to support Pokemoto’s growth strategy: Mike Spavelko, Vice President of Franchise Sales; Kimberly Tauch, Franchise Sales and Development Manager and Jennifer Holden, Director of Corporate and Franchise Training.  The new team members will support franchising expansion plans and training efforts for Pokemoto, which recently announced the signing of 25 new franchise agreements. Pokemoto is ramping up its resources and infrastructure to support its growth strategy by bringing on new team members...

Continue reading

vTv Therapeutics Shares Updated Corporate Presentation

HIGH POINT, N.C., Jan. 13, 2022 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company committed to improving the quality of life for people with diabetes, is sharing its updated corporate presentation highlighting its lead program TTP399, a novel oral liver-selective glucokinase activator, as a transformative treatment in the reduction of hypoglycemic episodes for the global diabetes population. Key Takeaways include:Hypoglycemia is common in people with type 1 diabetes and can occur quickly, with symptoms including sweating, nausea, coordination problems, headaches and even seizures. TTP399 may be used as a once-daily, oral adjunctive therapy in a $16B global insulin market for the reduction of hypoglycemic episodes. TTP399 has been tested in almost 600 patients to date with no evidence...

Continue reading

Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announces that 18 new patents were issued and 17 new patent applications were filed in 2021. The intellectual property is owned by Factor Bioscience (“Factor”) and exclusively licensed to Brooklyn for various fields of therapeutic use. The newly-issued patents encompass those covering the Company’s mRNA-based cellular reprogramming and gene editing technology, as well as nucleic acid delivery using Brooklyn’s ToRNAdo™ lipid nanoparticle technology (LNP). “We believe that the newly issued patents reflect the exceptional and innovative...

Continue reading

Grayscale Investments® Updates Pricing Methodology for Grayscale® Zcash Trust, Grayscale® Stellar Lumens Trust, and Grayscale® Horizen Trust

New York, Jan. 13, 2022 (GLOBE NEWSWIRE) — Grayscale Investments®, the sponsor (the “Sponsor”) of Grayscale® Zcash Trust (OTCQX: ZCSH), Grayscale® Stellar Lumens Trust (OTCQX: GXLM), and Grayscale® Horizen Trust (OTCQX: HZEN) (the “Trusts”) has updated the methodology used to determine the price of the Digital Assets underlying each of the Trusts.  Grayscale is issuing this release in accordance with the disclosure obligations of OTCQX®. The Trusts’ Quarterly Report and other disclosures, published to satisfy the Alternative Reporting Standard disclosure guidelines for OTCQX, are available at Grayscale® Zcash Trust, Grayscale® Stellar Lumens Trust, and Grayscale® Horizen Trust. Grayscale Zcash Trust and Grayscale Stellar Lumens Trust each values its Digital Assets for operational purposes by reference to the volume-weighted...

Continue reading

Year in Review and Looking to 2022

SAN JOSE, CA, Jan. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Sonasoft Corp. (OTCQB: SSFT), creators of the innovative Sonasoft AI Bot Runtime Engine, SAIBRE, closed out 2021 in a strong position. Highlights include tremendous progress in developing SAIBRE, a new strategic partnership, and a renewed focus on end-to-end AI projects. Taken together, this ensures that companies who engage Sonasoft will achieve a successful AI transformation, from data exploration and data science, through to delivery of a productionized AI solution. Sonasoft finds itself in a great position for 2022, ready to deliver new OEM partnerships that will help other companies overcome the challenging conditions created by COVID. SAIBRE Platform 2021 saw the announcement of SAIBRE, Sonasoft’s newly developed AI engine. SAIBRE cements Sonasoft’s position...

Continue reading

Harbor Custom Development, Inc. to Present at the Sidoti & Company Virtual Small Cap Conference Live Via Webcast

Gig Harbor, Washington , Jan. 13, 2022 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (Nasdaq: HCDI, HCDIP, HCDIW, HCDIZ) (“Harbor,” “Harbor Custom Homes®,” or the “Company”), an innovative and market leading real estate company involved in all aspects of the land development cycle, will present virtually to the investment community via webcast at the Sidoti & Company Virtual Small Cap Conference on Thursday, January 20, 2022, at 12:15 p.m. (EDT). The live broadcast of the presentation may be accessed under the events and presentations section of Harbor Custom Development’s investor website at https://investors.harborcustomhomes.com. Participants are encouraged to log on at least five minutes prior to the start of the presentation. About Harbor Custom Development, Inc. Harbor Custom Development, Inc. is a real estate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.